Transarterial Chemoembolization [topp]    
Curative [cnce]    
resection [topp]    
HEPATOCELLULAR CARCINOMA [neop]    
Propensity Score [qnco]    
Survival [acty]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
Receive [qlco]    
Transarterial Chemoembolization [topp]    
Methods [inpr]    
CONSECUTIVE SAMPLE [popg]    
Patients [podg]    
Curative [cnce]    
resection [topp]    
March [qlco]    
March [qlco]    
included [ftcn]    
Patients [podg]    
Curative [cnce]    
resection [topp]    
Transarterial Chemoembolization [topp]    
Curative [cnce]    
resection [topp]    
Alone [qnco]    
Order [inpr]    
baseline [bodm]    
Groups [idcn]    
Comparison [acty]    
Conduct [inbe]    
Propensity Score [qnco]    
matched [resa]    
Patients [podg]    
Survival [acty]    
Compared [acty]    
Independent [idcn]    
Survival [acty]    
Identified [qlco]    
Proportional [qlco]    
Hazard [qlco]    
Regression [patf]    
Pair [qlco]    
Propensity Score [qnco]    
matched [resa]    
Patients [podg]    
YEAR [tmco]    
overall survival rate [qnco]    
Transarterial Chemoembolization [topp]    
Group [idcn]    
Control Group [grup]    
SAME [qlco]    
TIME [tmco]    
Transarterial Chemoembolization [topp]    
Control Groups [grup]    
YEAR [tmco]    
> 2 years [fndg]    
YEARS [tmco]    
Regression [patf]    
Identified [qlco]    
Serum alpha-fetoprotein level [lbtr]    
Tumour size [spco]    
Independent [idcn]    
Risk Factors [qnco]    
Mortality [qnco]    
Postoperative [tmco]    
Transarterial Chemoembolization [topp]    
Survival [acty]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
Study [mnob]    
Needed [qlco]    
Clarify [acty]    
Benefit [qnco]    
